Anticancer activity of cardiac glycosides: At the frontier between cell-autonomous and immunological effects

Anticancer activity of cardiac glycosides: At the frontier between cell-autonomous and immunological effects

Retrospective clinical data indicate that cardiac glycosides (CGs), notably digoxin, prolong the survival of carcinoma patients treated with conventional chemotherapy. CGs are known to influence the immune response at multiple levels. In addition, recent results suggest that CGs trigger the immunoge...

Full description

Bibliographic Details
Main Authors: Kepp, Oliver, Menger, Laurie, Vacchelli, Erika, Adjemian, Sandy, Martins, Isabelle, Ma, Yuting, Sukkurwala, Abdul Qader, Michaud, Mickaël, Galluzzi, Lorenzo, Zitvogel, Laurence, Kroemer, Guido
Format: Online
Language:English
Published: Landes Bioscience 2012
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3525630/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3525630/

Similar Items